Back to Search Start Over

A Case of Exacerbation of Subclinical Hyperthyroidism after First Administration of BNT162b2 mRNA COVID-19 Vaccine.

Authors :
Yamamoto K
Mashiba T
Takano K
Suzuki T
Kami M
Takita M
Kusumi E
Mizuno Y
Hamaki T
Source :
Vaccines [Vaccines (Basel)] 2021 Sep 29; Vol. 9 (10). Date of Electronic Publication: 2021 Sep 29.
Publication Year :
2021

Abstract

COVID-19 vaccines are the most critical measure for controlling the COVID-19 pandemic; however, we have little information on their complications. We experienced a case of a patient who developed hyperthyroidism complicated with atrial fibrillation and heart failure on the sixth day after the first dose of COVID-19 vaccination. This case report shows the importance of considering hyperthyroidism as a possible complication after COVID-19 vaccination.

Details

Language :
English
ISSN :
2076-393X
Volume :
9
Issue :
10
Database :
MEDLINE
Journal :
Vaccines
Publication Type :
Report
Accession number :
34696214
Full Text :
https://doi.org/10.3390/vaccines9101108